Back
Novartis AG Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
76
NVSEF
Novartis AG
Last Price:
100.63
Seasonality Move:
1.98%
Buy
71
CRSP
CRISPR Therapeutics AG
Last Price:
52.33
Seasonality Move:
15.03%
Buy
76
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVSEF] share price is $100.63. The Score for NVSEF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $55.15. The Score for CRSP is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $100.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.07 | Sell |
| Relative Strength Index (14 RSI): | 40.79 | Sell |
| Chaikin Money Flow: | -1592 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.47 - 108.15) | Sell |
| Bollinger Bands (100): | (105.02 - 114.92) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 65.76 | Buy |
| Chaikin Money Flow: | 3042314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.31 - 51.97) | Buy |
| Bollinger Bands (100): | (45.51 - 53.53) | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.12 | Sell |
| 20-day SMA: | 103.89 | Sell |
| 50-day SMA: | 108.21 | Sell |
| 200-day SMA: | 104.77 | Sell |
| 8-day EMA: | 102 | Sell |
| 20-day EMA: | 103.78 | Sell |
| 50-day EMA: | 106.79 | Sell |
| 200-day EMA: | 104.88 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.79 | Buy |
| 20-day SMA: | 49.86 | Buy |
| 50-day SMA: | 48.22 | Buy |
| 200-day SMA: | 56.6 | Sell |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 49.69 | Buy |
| 50-day EMA: | 49.12 | Buy |
| 200-day EMA: | 53.18 | Buy |
Novartis AG Earnings Growth & NVSEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
Novartis AG Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||